As a 62-year-old grandmother in Maine, Christine Babb doesn’t identify with the biohacker bros who try experimental medications to optimize their health. But after side effects from her first dose of a weight-loss drug hit her “like a Mack truck,” she, too, decided to experiment.
What readers are saying
The comments reflect a mix of skepticism and cautious optimism about microdosing GLP-1 drugs for longevity. Some users express concern over the lack of scientific evidence and the influence of Big Pharma, while others share personal success stories with GLP-1s, noting... Show more
This summary is AI-generated. AI can make mistakes and this summary is not a replacement for reading the comments.- 1Dylan WellsandJoe LambertiCan Democrats rebound? These voters aren’t so sure.
- 2Frances VinallSNL revamps its roster. Meet the show’s five new cast members.
- 3ColumnCarolyn HaxCarolyn Hax: Wedding opens new front in cold war with late wife’s sister
- 4Jeremy RoebuckFederal appellate panel rejects Trump’s deportations under wartime law
- 5ColumnMichelle SingletaryA $1.3 billion Powerball win sounds life-changing. Here’s the catch.
NewsletterDaily
Today’s Headlines
The most important news stories of the day, curated by Post editors, delivered every morning.